Skip to main content
logo
Lin BioScience, Inc. (TPEX:6696)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
731.00
+27.00 (3.84%)
Aug 6, 2026, 9:20 AM CST

Lin BioScience Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
58,31032,84210,8128,94612,58312,832
Market Cap Growth
368.35%203.77%20.85%-28.90%-1.94%83.66%
Enterprise Value
56,44230,1558,4977,78811,31411,817
Last Close Price
704.00397.00136.58113.24170.33180.59

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
2.321.312.022.617.2528.33
P/TBV Ratio
5.493.093.954.4111.1828.87

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.010.010.030.01
Net Debt / Equity Ratio
-0.65-0.65-0.97-0.94-0.92-1.78
Net Debt / EBITDA Ratio
5.715.713.572.953.612.39
Net Debt / FCF Ratio
11.2311.235.053.174.172.76
Quick Ratio
57.6857.6833.6623.7020.601.72
Current Ratio
58.1858.1834.4524.6920.941.74
Return on Equity (ROE)
-16.93%-16.93%-28.66%-41.08%-41.98%-70.57%
Return on Assets (ROA)
-11.54%-11.54%-19.97%-25.16%-20.05%-19.74%
Return on Capital Employed (ROCE)
-11.40%-11.40%-27.10%-31.70%-25.10%-74.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-2.34%-4.15%-6.88%-7.68%-2.49%-3.39%
FCF Yield
-2.48%-4.41%-9.48%-11.34%-3.05%-2.27%
Buyback Yield / Dilution
-4.46%-4.46%-6.24%-3.14%-4.27%-10.73%